��������

The Leadership Team at Olatec Therapeutics is responsible for guiding the company's strategic direction and overseeing the development of its proprietary NLRP3 antagonist therapeutics. This team, comprised of executives with expertise in medicine, finance, compliance, and clinical operations, ensures alignment between research initiatives and business objectives while fostering an environment of innovation to address complex inflammatory diseases. They play a critical role in decision-making, regulatory compliance, and the allocation of resources to advance Olatec’s mission.